Goran Ando

Insider Reports History

Location
Princeton, NJ
Signature
/s/ Ron Honig, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Goran Ando:

Company Role Class Num Shares Value Price $ Report Date Ownership
SELECTA BIOSCIENCES INC Director Stock Option (Right to Buy) 75,000 $59,250 $0.7900 02 Jan 2023 Direct
EyePoint, Inc. Director Stock Option (Right to Buy) 41,500 02 Jan 2026 Direct

Insider Reports Filed by Goran Ando

Symbol Company Period Transactions Value $ Form Type Role Filing Time
EYPT EyePoint, Inc. 02 Jan 2026 1 $0 4 Director 06 Jan 2026, 16:05
EYPT EyePoint Pharmaceuticals, Inc. 03 Jan 2025 1 $0 4 Director 07 Jan 2025, 16:04
EYPT EyePoint Pharmaceuticals, Inc. 21 Aug 2024 1 +$39,750 4 Director 21 Aug 2024, 16:01
EYPT EyePoint Pharmaceuticals, Inc. 05 Jan 2024 1 $0 4 Director 09 Jan 2024, 20:53
EYPT EyePoint Pharmaceuticals, Inc. 20 Jun 2023 2 $0 4 Director 22 Jun 2023, 09:19
EYPT EyePoint Pharmaceuticals, Inc. 09 Feb 2023 2 $0 4 Director 13 Feb 2023, 16:04
RNAC SELECTA BIOSCIENCES INC 02 Jan 2023 1 $0 4 Director 04 Jan 2023, 16:04
EYPT EyePoint Pharmaceuticals, Inc. 09 Feb 2022 4 $0 4 Director 11 Feb 2022, 15:48
RNAC SELECTA BIOSCIENCES INC 03 Jan 2022 1 $0 4 Director 05 Jan 2022, 15:31
EYPT EyePoint Pharmaceuticals, Inc. 22 Jun 2021 2 $0 4 Director 23 Jun 2021, 17:29
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .